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The therapeutic potential of brown 
adipocytes in humans
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1 Metabolism Unit, Shriners Hospitals for Children-Galveston, Galveston, TX, USA, 2 Department of Surgery, University of 
Texas Medical Branch, Galveston, TX, USA, 3 Department of Preventive Medicine and Community Health, University of Texas 
Medical Branch, Galveston, TX, USA, 4 Department of Nutrition and Dietetics, Harokopio University of Athens, Athens, 
Greece, 5 Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA
Obesity and its metabolic consequences represent a significant clinical problem. From a 
thermodynamic standpoint, obesity results from a discord in energy intake and expen-
diture. To date, lifestyle interventions based on reducing energy intake and/or increasing 
energy expenditure have proved ineffective in the prevention and/or treatment of obesity, 
owing to poor long-term adherence to such interventions. Thus, an effective strategy 
to prevent or correct obesity is currently lacking. As the combustion engines of our 
cells, mitochondria play a critical role in energy expenditure. At a whole-body level, 
approximately 80% of mitochondrial membrane potential generated by fuel oxidation is 
used to produce ATP, and the remaining 20% is lost through heat-producing uncoupling 
reactions. The coupling of mitochondrial respiration to ATP production represents an 
important component in whole-body energy expenditure. Brown adipose tissue (BAT) is 
densely populated with mitochondria containing the inner mitochondrial proton carrier 
uncoupling protein 1 (UCP1). UCP1 uncouples oxidative phosphorylation, meaning that 
mitochondrial membrane potential is dissipated as heat. The recent rediscovery of BAT 
depots in adult humans has rekindled scientific interest in the manipulation of mitochon-
drial uncoupling reactions as a means to increase metabolic rate, thereby counteracting 
obesity and its associated metabolic phenotype. In this article, we discuss the evidence 
for the role BAT plays in metabolic rate and glucose and lipid metabolism in humans and 
the potential for UCP1 recruitment in the white adipose tissue of humans. While the future 
holds much promise for a therapeutic role of UCP1 expressing adipocytes in human 
energy metabolism, particularly in the context of obesity, tissue-specific strategies that 
activate or recruit UCP1 in human adipocytes represent an obligatory translational step 
for this early promise to be realized.
Keywords: adipose tissue, mitochondria, uncoupling protein 1, thermogenesis, obesity
introduction
Obesity and its associated metabolic complications (hyperlipidemia, insulin resistance, and glu-
cose intolerance) have become significantly more prevalent in the United States and around the 
world in recent years (1, 2). One third of Americans are either obese (1) or exhibit symptoms 
of pre-diabetes (3). Worldwide, excessive adiposity is responsible for more than three million 
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deaths and is a significant cause of disability (4). Increasing 
adiposity is associated with derangements in glucose and lipid 
metabolism and in the development of insulin resistance (5, 6). 
Therapeutic strategies aimed at preventing obesity or treating its 
metabolic complications typically target dietary intake and/or 
physical activity, but to date do not seem to exhibit a great deal 
of long-term efficacy. Mitochondrial proton leaks, i.e., respira-
tion uncoupled from ATP production, accounts for around 20% 
of total mitochondrial respiration (7). The physiological role 
ascribed to this uncoupling of oxidative phosphorylation is heat 
production (thermogenesis). While thermogenesis represents a 
significant portion (~20%) of whole-body energy expenditure (7, 
8), its therapeutic role in energy metabolism has only recently 
begun to receive attention.
Brown adipose tissue (BAT) is the major tissue responsible 
for non-shivering thermogenesis in mammals (9). The recent 
(re)discovery of BAT in human adults (10–12) has triggered sci-
entific interest in the role of BAT in human energy metabolism. 
Unique features of BAT include an abundance of mitochondria 
that contain the transmembrane carrier protein thermogenin, 
most commonly referred to as uncoupling protein 1 (UCP1) 
(13). Upon activation by long-chain fatty acids, UCP1 acts as 
an inner mitochondrial proton carrier (14), allowing protons 
to reenter the mitochondrial matrix independently of ATP 
synthase, thus uncoupling mitochondrial respiration from ATP 
production (9). This process alters mitochondrial energy trans-
duction, where mitochondrial membrane potential is lost as 
heat (Figure 1). The purpose of this review is to summarize the 
current evidence regarding the role of the human adipose tissue 
as a therapeutic target against obesity and its related metabolic 
complications.
The Role of Brown Adipose Tissue in 
energy Balance and Obesity
Although the role of BAT in energy metabolism and obesity has 
been studied in detail in rodents (15–17), our understanding of 
the role BAT plays in human energy metabolism remains in its 
infancy. For obvious reasons, it is more difficult to manipulate 
and study BAT in humans. Retrospective reviews of medical 
records and positron emission tomography–computed tomog-
raphy (PET/CT) scans, originally performed for diagnostic 
purposes, demonstrate an association between BAT and body 
mass index (BMI) (10, 18, 19) and with non-alcoholic fatty liver 
disease (20). The retrospective nature of these studies along 
with the fact that the PET/CT scans were performed under 
non-standardized conditions limit the generalizability of these 
data. However, these findings are bolstered by prospective stud-
ies which report a correlation between BAT volume and activity 
with BMI (11, 21), total fat mass (11, 21), and both abdominal 
subcutaneous and visceral adiposity (21). Moreover, weight loss 
via bariatric surgery has been linked to increased BAT activity 
(22), further suggesting that BAT may contribute to energy bal-
ance in human beings.
Acute (non-shivering) cold exposure studies have been 
recently performed in an attempt to estimate the contribution of 
BAT to cold-induced energy expenditure. However, the reported 
results have been highly variable. These studies reported that 
acute cold exposure (2–4 h at 16–19°C) induces BAT activation, 
resulting in a 13–27% increase in resting energy expenditure 
(REE) (11, 23, 24). In contrast, Ouellet et al. reported an 80% 
increase in REE with acute cold exposure (for 2  h at ~18°C) 
(25), a result over threefold higher than those of other stud-
ies, possibly attributable to muscle shivering. Muzik et  al. 
used oxygen 15 (15O)-PET/CT in an attempt to more directly 
quantify the contribution of BAT to energy expenditure (26, 27). 
In contrast to previous studies, these investigators found that 
BAT minimally contributed to the reported increase in energy 
expenditure (15–25 kcal/day). Although these two studies shed 
doubt on the role of BAT in energy expenditure in humans, 
the rather short cold stimulation protocol (30  min at 18°C) 
may not have been adequate to fully activate BAT. Indeed, BAT 
recruitment via daily mild cold exposure (17°C for 6 weeks) was 
associated with increased thermogenesis and decreased body 
fat, supporting a relationship between BAT activity and adipos-
ity (28). Similarly, Lee et al. performed a crossover cold acclima-
tion study in five healthy participants. These researchers showed 
that BAT recruitment was reversibly associated with increased 
post-prandial energy expenditure (diet-induced thermogenesis) 
after cold exposure, further supporting the role of BAT in energy 
expenditure (29).
When interpreting the results of these studies, one important 
point to consider is that chronic weight gain can result from 
even a small discordance in daily energy balance (e.g., an energy 
surplus of as little as 25 kcal/day in humans can result in a weight 
gain of 1 kg/year). Thus, even sporadic BAT activation for limited 
periods during the course of the day could conceivably have a 
significant cumulative impact on energy balance and adiposity 
over several months or years.
Can Human Brown Adipose Tissue Alter 
Glucose Homeostasis and insulin 
Sensitivity?
Brown adipose tissue has been touted as therapeutic tissue 
which may protect against hyperglycemia in insulin-resistant 
individuals. In murine models of extreme cold exposure, BAT 
is responsible for the majority of whole-body glucose disposal 
(30), while transplantation of BAT into the abdominal visceral 
adipose tissue improves glucose tolerance and insulin sensitivity 
(31). In humans, the involvement of BAT in systemic glucose 
metabolism is evident from 18F-FDG uptake images from PET/
CT scans (Figure  2) performed for diagnostic purposes (32). 
Moreover, evidence from retrospective medical record review 
studies indicates an inverse relationship between BAT activity, 
diabetes, and glycemia (10, 19, 33, 34). Further, prospective 
studies have shown that acute cold exposure increases glucose 
uptake in BAT, where BAT glucose uptake rate per unit of tissue 
was higher than that of muscle (25, 35, 36), underscoring the 
oxidative potential of BAT. Specifically, Orava et al. reported that 
cold exposure resulted in a 12-fold increase in glucose disposal 
in BAT only, but not in other tissues (35). Similar results have 
been reported by Ouellet et al. (25). These data suggest that upon 
FiGURe 2 | Coronal (left) and transverse (right) 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG) positron emission tomography (PeT)-computed 
tomography (CT) images from a volunteer during cold exposure. The intense orange color in the supraclavicular area corresponds to brown adipose tissue. 
Image from Ref. (24). Reprinted with permission.
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activation, BAT clears plasma glucose. However, Ouellet et  al. 
demonstrated that BAT minimally contributed to whole-body 
plasma glucose utilization, which might be due to the short dura-
tion of cold exposure (3 h at ~18°C) and the presence of mild 
shivering during cold exposure (25).
The opposing results of the aforementioned studies question 
the physiological significance of human BAT in systemic glucose 
metabolism. In an attempt to address this, we studied glucose 
metabolism in individuals with BAT (BAT+) or without BAT 
(BAT−) under cold exposure and thermoneutral conditions by 
infusing isotopically labeled glucose in the fasted state and during 
FiGURe 1 | Schematic overview of mitochondrial energy transduction within a brown adipocyte mitochondrion. Norepinephrine (NE) activation of 
adrenergic receptors (AR) causes an increase in cytosolic cyclic adenosine monophosphate (cAMP) levels. The subsequent activation of lipases results in the 
lipolysis of triacylglycerol (TAG), which increases intracellular free fatty acid (FFA) concentrations. FFAs fulfill two principal metabolic fates: (i) FFAs bind to and activate 
uncoupling protein 1 (UCP1), thus switching on UCP1-mediated proton (H+) conductance. (ii) Activated FFAs (acyl-CoA) can be transported into the mitochondrion 
via the carnitine palmitoyl transferase (CPT) system and be oxidized to acetyl-CoA, thereby potentiating anaplerosis and providing reducing equivalents for the 
electron transport chain (ETC). Pyruvate also participates in mitochondrial anaplerosis and the production of reducing equivalent by being decarboxylated to 
acetyl-CoA by pyruvate dehydrogenase (PDH) or being carboxylated by pyruvate carboxylase (PC), forming oxaloacetate (OAA).
a hyperinsulinemic-euglycemic clamp. We found that cold expo-
sure increased whole-body glucose disposal in the fasted and 
insulin-stimulated state only in BAT+ individuals (24), suggest-
ing that BAT can indeed play a significant role in systemic glucose 
metabolism in humans. Theoretically, if BAT remained chroni-
cally active, it could dispose ~23 g of glucose in 24 h [equating to 
approximately 8.4 kg of glucose (33,600 kcal) in a year]. Similarly, 
Lee et al. recently reported that increased BAT activity via cold 
acclimation improved post-prandial glycemia (29). Collectively, 
these studies support the notion that upon activation, BAT can 
indeed play a significant role in glucose homeostasis. Therefore, 
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BAT may represent a novel therapeutic target in the management 
of hyperglycemia.
Does Human Brown Adipose Tissue Play a 
Role in Systemic Lipid Metabolism?
Free fatty acids (FFAs) constitute the primary substrate for BAT 
(37). Moreover, FFAs bind to and activate UCP1, allowing pro-
ton transfer from the intermembrane space to the mitochon-
drial matrix resulting in heat production (9). Upon activation, 
BAT initially oxidizes intracellular lipid stores to produce heat 
(9). In contrast, prolonged BAT stimulation leads to increased 
uptake of FFA derived from circulating FFA and lipolysis of 
circulating lipoproteins, presumably when local lipid stores 
become depleted (9). BAT activation has been recently reported 
to increase the systemic clearance of TG-rich lipoproteins in 
rodents, lending credence to the notion that BAT may protect 
against hyperlipidemia (30, 38). Moreover, rodent BAT has been 
shown to release factors that increase vascular permeability 
in BAT, allowing TG-rich lipoproteins to enter the interstitial 
space (30).
The role of BAT in human lipid metabolism remains largely 
unexplored. Results from some (11, 35), but not all (23), cold 
exposure studies report a reduction in the respiratory gas 
exchange ratio during cold exposure, indicating increased 
fat oxidation in humans during BAT activation. Ouellet et al. 
(25) studied the role of BAT in lipid metabolism in more 
detail. Using PET/CT and a fatty acid tracer, 18F-fluoro-
thiaheptadecanoic acid (18FTHA), they showed that 3 h of cold 
exposure increased BAT FFA uptake but that this accounted for 
<1% of the total FFA turnover (25). The conclusion of this study 
was that thermogenic BAT relies predominantly on the limited 
intracellular substrates (i.e., triglycerides stored inside BAT) to 
fuel mitochondrial thermogenesis (25), which questions the 
physiological significance of human BAT in whole-body lipid 
metabolism. However, the relatively short duration of the study 
might have been insufficient to deplete the intracellular lipid 
stores underestimating the contribution of BAT in the systemic 
lipid metabolism.
We recently studied BAT+ and BAT− individuals under mild 
cold exposure and thermoneutral conditions while infusing 
stable isotopes of glycerol and palmitate in order to directly trace 
lipid turnover in the fasted state and during a hyperinsulinemic-
euglycemic clamp. We found that during cold exposure BAT+ 
individuals had greater whole-body lipolysis and FFA oxidation 
compared with BAT− participants, indicating that increased lipid 
mobilization from WAT provides FFA to sustain thermogenesis 
in BAT (39). Moreover, BAT+ individuals were protected from 
the cold-induced adipose tissue insulin resistance noted in the 
BAT− group (40). Our data suggest that BAT may indeed play 
an important role in the regulation of systemic lipid metabolism. 
The discord between our preliminary findings and those of others 
(25) may be related to the duration of cold exposure. For example, 
we studied individuals after ~5 h of cold exposure, while Ouellet 
et al. performed a 3 h cold exposure study. Whether there is a 
time-dependent depletion of BAT lipid stores, at which point 
BAT switches to using systemic FFAs as a fuel source, remains 
unknown.
Can Human wAT Really Brown?
More than 30  years ago, Young et  al. demonstrated the 
appearance of brown adipocytes in the parametrial fat pad 
of mice following acclimation to severe cold exposure (41). 
This was confirmed when Cousin et  al. demonstrated that 
severe cold exposure or treatment with a β3 adrenorecep-
tor agonist induced brown adipocytes within WAT (42). 
More recently, Shabalina et  al. demonstrated that acclima-
tion to cold (~5°) results in the browning of inguinal WAT. 
Importantly, these researchers showed the presence of UCP1 
protein while demonstrating its function (via GDP-sensitive 
respiration) in inguinal WAT of cold-acclimated mice (43), 
thus demonstrating that these mitochondria had functional 
UCP1. Interestingly, per milligram of tissue, inguinal WAT 
from cold-acclimated mice developed a thermogenic capacity 
~50% of that of intrascapular BAT (43). This striking plastic-
ity of murine subcutaneous WAT to develop a thermogenic 
phenotype has potential implications for humans, given that 
most individuals have only 100  g or less of BAT, but many 
kilograms of subcutaneous WAT. If WAT in humans were able 
to exhibit the same plasticity as in mice, this would have huge 
implications for energy expenditure and substrate (glucose, 
lipids, and potentially amino acid) metabolism.
Unlike the inguinal subcutaneous WAT depot of mice, there 
is no evidence to suggest that human WAT has a comparable 
ability to alter its thermogenic capacity in response to an envi-
ronmental stress. Indeed, chronic (10  days), albeit mild cold 
exposure, which activates BAT, does not alter the phenotype of 
WAT in humans (44). This suggests that a more profound and/
or chronic adrenergic stress is likely needed to induce browning 
in humans. Indeed, this is perhaps reasonable considering that 
classic rodent models of browning typically acclimate rodents 
to extremely cold temperatures (~5°C) for several days, if not 
weeks (41–43). Considering that a thermoneutral temperature 
for a mouse is somewhere close to 30°C, it would be reasonable 
to theorize that chronic exposure to a temperature 25°C below 
thermoneutrality would be required to induce browning of 
WAT in humans. 
Since cold exposure protocols used in rodents cannot be 
replicated in humans, researchers have looked to pathologies 
associated with chronic adrenergic stress. Over 30 years ago, it 
was reported that patients with pheochromocytoma, a tumor 
of the adrenal medulla which results in a chronic elevation in 
catecholamine secretion, had BAT surrounding their kidneys 
(45). More recently, Frontini et al. (46) reported the existence of 
multilocular adipocytes that stained positive for UCP1 within 
the omental adipose tissue of pheochromocytoma patients. 
This evidence suggests that human WAT may contain brown 
adipocytes, but unfortunately only histological and genomic 
measurements were made on these WAT samples. Whether 
these omental adipocytes, which showed morphological simi-
larities to that of brown adipocyte and immune-reactivity to 
TABLe 1 | impact of acute non-shivering cold exposure and severe burns 
on whole-body energy expenditure.
Normala  
(kcal/day)
Cold exposure 
(kcal/day)
Severe burnsd  
(kcal/day)
BAT 1 (0.1) 127 (7.0)c 191 (6.3)e
WAT 68 (4.0)b 68 (3.7) 205 (6.7)f
Muscle 368 (21.7) 368 (20.2) 748 (24.5)
Liver 362 (21.3) 362 (19.8) 684 (22.4)
Heart 146 (8.6) 146 (8.0) 368 (12)
Kidney 137 (8.1) 137 (7.5) 244 (8.0)
Brain 338 (19.9) 338 (18.5) 338 (11.1)
Other 277 (16.3) 277 (15.2) 277 (9.1)
Whole body 1697 1823 3053
Values for each organ/tissue are presented as kilocalories/day with the percent 
contribution to whole-body energy expenditure in brackets.
aValues for thermoneutral conditions are taken from Rolfe and Brown (7).
bValues for white adipose tissue (WAT) are taken from Gallagher et al. (48).
cValues for cold exposure (5 h at ~18°) were derived from Chondronikola et al. (24), 
assuming a 7.5% increase in resting energy expenditure following acute cold exposure, 
which was attributable to brown adipose tissue (BAT) activation.
dValues for burn victims are taken from Wilmore and Aulick (49) for a patient with full-
thickness burns encompassing ≥50% of their total body surface area, which results in 
an 80% increase in resting energy expenditure.
eAs chronic cold exposure results in a 50% increase in BAT volume [van der Lans 
et al. (44)], BAT values derived from Chondronikola et al. (24) were multiplied by a 
factor of 1.5.
fWAT values for healthy individuals derived from Gallagher et al. (48) were multiplied 
by a factor of 3 to account for the increase in leak respiratory capacity of WAT seen in 
burn victims (47).
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UCP1, had functionally thermogenic mitochondria was not 
addressed.
Burn trauma represents a unique injury model as it is accom-
panied by prolonged adrenergic stress and a hypermetabolic 
state. To determine if subcutaneous WAT can acquire a brown fat 
phenotype, we collected biopsy samples of WAT from severely 
burned individuals. We found that when prospectively following 
patients after burn injury, UCP1 mRNA and UCP1 protein were 
induced in subcutaneous WAT at ~2  weeks post-injury (47). 
Moreover, this was accompanied by a similar time-dependent 
increase in mitochondria respiratory capacity and whole-body 
metabolic rate (47). Thus, it appears that human subcutaneous 
WAT has the ability to brown. In the context of burn trauma, 
this makes physiological sense, since following the destruction of 
their skin barrier burn victims have difficulty in conserving heat 
and maintaining core temperature.
To the best of our knowledge, our recent data provide the 
first evidence of browning of WAT in humans (47). However, 
we should note that while we did indeed see induction of UCP1, 
morphological adaptations, and increased mitochondrial respira-
tory in permeabilized WAT samples in a time-dependent manner 
after burn, the increase in thermogenic capacity (~threefold) was 
rather modest when compared with those seen in rodent WAT 
after chronic cold exposure. For example, Shabalina et  al. (43) 
showed that the mitochondrial respiratory capacity of mitochon-
dria isolated from the BAT of mice kept at 30°C was ~10-fold 
greater than that of mitochondria isolated from inguinal WAT. 
However, when acclimated to 5°C, the respiratory capacity of 
BAT mitochondria was only ~1.7-fold greater than that of ingui-
nal WAT mitochondria. Indeed, BAT mitochondrial respiratory 
capacity was only marginally greater in cold-acclimated mice 
compared with thermoneutral mice. In contrast, WAT mitochon-
drial respiratory capacity was ~500% greater in inguinal WAT 
of cold-acclimated mice compared with thermoneutral animals. 
This remarkable plasticity, where murine inguinal WAT can adopt 
a thermogenic capacity akin to that of BAT, does not appear to 
be conserved in other mammals such as humans. Indeed, while 
we saw a threefold increase in subcutaneous WAT respiratory 
capacity after burn injury, respiration per milligram of tissue 
was still ~20-fold lower than what we have measured in human 
intrascapular BAT (47).
The Therapeutic Potential of  
UCP1-Positive Mitochondria: Should  
we Activate BAT or Brown wAT?
Much emphasis has been placed on manipulating UCP1 in order 
to increase thermogenesis and thus energy expenditure, which 
over time would reduce adiposity and consequently correct 
metabolic abnormalities associated with obesity. Broadly speak-
ing, manipulation of UCP1 can be classified into two distinct 
ways: (i) acute activation of existing UCP1 and (ii) induction of 
UCP1. Induction of UCP1 can take several forms, i.e., the expan-
sion of existing BAT depots, producing more UCP1 per gram 
of BAT, or inducing UCP1 within WAT (browning). However, 
the significance of either activating UCP1 within classical BAT 
depots or browning WAT in humans in terms of energy expendi-
ture remains unclear. Using available data on organ-specific 
metabolic rates, and our own data on (a) the metabolic rate of 
human BAT following acute cold exposure and (b) human WAT 
that has undergone browning, we present theoretical calculations 
to estimate the potential impact of UCP1 on energy expenditure 
in humans (Tables 1 and 2).
Since UCP1 is inactive in the presence of inhibitory purine 
nucleotides such as ATP (50), BAT makes a negligible contribution 
to whole-body REE given that ~100 g of BAT represents ~0.1% of 
total body mass of a 70 kg individual. Similarly, in an individual 
with ~20% total fat mass, WAT accounts for a small (~4%) por-
tion of whole-body REE (48) (see Table 1). Following acute (5 h) 
acclimation to mild cold (5 h at ~18°), our data (24) suggest that 
on average there is a 7.5% increase in REE. This acute intervention 
transforms BAT from being a quiescent tissue to one that makes 
a comparable contribution to whole-body REE as the heart or the 
kidneys (Table  1). In a 70  kg individual, this activation of BAT 
increases REE by 127  kcal (Table  1), which if maintained for 
30 days would combust 0.5 kg of adipose tissue.
Burn trauma results in a significant increase in REE (51), 
which persists for months if not years post injury (52). While 
many ATP-consuming processes increase after burn, increased 
ATP turnover only explains 50–60% of burn-induced hyper-
metabolism (53). This means that thermogenesis represents a 
significant portion of hypermetabolism in burn victims, which 
makes sense since these patients have a compromised skin bar-
rier and inability to thermoregulate. In order to estimate the 
TABLe 2 | The contribution of various tissues to the increase in whole-
body metabolic rate accompanying acute non-shivering cold exposure 
and severe burns.
Cold exposure Severe burns
Δ kcal/day % of increase Δ kcal/day % of increase
BAT 126 100 190 14
WAT 0 – 136 10
Muscle 0 – 379 28
Liver 0 – 322 24
Heart 0 – 222 16
Kidney 0 – 107 8
Brain 0 – 0 0
Other 0 – 0 0
Whole body 126 100 1356 100
Values for acute cold exposure and severe burn injury reported in Table 1 are 
presented as the change (Δ) from healthy values and also as a percentage (%) of the 
increase in whole-body energy expenditure.
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potential contribution of BAT used burn injury as a model of 
severe adrenergic stress which is accompanied by hypermetabo-
lism. We made calculations of whole-body and tissue-specific 
energy expenditure based on a patient with a burn covering 50% 
of their total body surface area, which resulted in an 80% increase 
in REE (49).
While the impact of burn trauma on BAT is largely unknown, 
we theorized that like chronic intermittent cold exposure, pro-
longed adrenergic stress following severe burn trauma would 
expand BAT depots. Assuming an ~50% increase in BAT volume 
as seen with 10  days of mild cold exposure (44), BAT would 
account for 191  kcal of total REE (Table  1). Here, while BAT 
makes a greater contribution to REE in absolute terms, since burn 
injury results in a large increase in REE, the relative contribution 
of BAT to whole-body REE is slightly lower (6.3%) when com-
pared to cold exposure (7%) (Table 1). Perhaps more strikingly, 
when considering WATs contribution to REE in burn victims, the 
threefold increase in thermogenic capacity we found in subcuta-
neous WAT of burn victims would increase WATs contribution 
to whole-body REE to ~7% (Table 1). Thus, WAT and BAT may 
make similar absolute and relative contributions to whole-body 
REE in burn survivors. Again though, we should point out that 
these calculations are based on an individual with around 100 g of 
BAT and 15 kg of WAT, underscoring the profound difference in 
thermogenic potential per gram of tissue between BAT and WAT.
While the chronic adrenergic stress accompanying severe burn 
trauma provides a unique model where human WAT undergoes 
browning, it also offers significant insight into the physiological 
impact of achieving UCP1 activation and recruitment. In Table 2, 
we present the values reported in Table  1 as the change from 
normal and also as a percentage in which each tissue contributes 
to the increase in whole-body REE. While the 127 kcal increase in 
REE following acute cold exposure is attributable to BAT, several 
organs contribute to the massive (1230  kcal) increase in REE 
following burn severe trauma. For example, while burn trauma 
may result in large absolute increases in BAT and WAT metabolic 
rates, their relative contributions to total REE are less impressive. 
Indeed, skeletal muscle (28%), the liver (24%), and the heart 
(16%) contribute most to burn-induced hypermetabolism, fol-
lowed by BAT (14%) and WAT (10%) (Table 2).
We make the point above to underscore the fact that while the 
chronic stress response to burns may augment BAT and WAT 
thermogenesis, the systemic milieu which brings these adapta-
tions in adipose tissue energy expenditure likely impacts many 
other organs. While our data on burn victims (47) provide novel 
evidence that human WAT can indeed undergo browning under 
very severe and extended adrenergic stress, this extreme patho-
physiological state has an impact on nearly every organ system in 
the body. Thus, with all the available evidence to date, we suggest 
that the therapeutic potential of UCP1-positive mitochondria in 
combating obesity and its metabolic complications will likely be 
realized in humans by the acute activation of existing BAT and/
or the expansion of BAT depots. If WAT browning holds any 
therapeutic potential in the context of obesity, the development 
of safe tissue-specific agents to induce browning is needed before 
this potential can be realized.
Summary
Adipocytes with an abundance of UCP1-positive mitochondria 
are unique in that gram for gram they have a respiratory capacity 
akin to that of muscle or liver, yet only minimal ability to produce 
ATP. The physiological role ascribed to this adaptation in mito-
chondrial energy transduction is heat production, facilitating 
thermoregulation in mammals. In the context of the global obe-
sity epidemic, there is now much interest in the environmental 
and/or pharmacological exploitation of this thermoregulatory 
mechanism, since increased metabolic rate will combat obesity 
and the deleterious metabolic phenotype it incurs. In humans, a 
growing body of evidence suggests that acute activation of BAT 
can indeed have a meaningful impact on REE and intermediary 
glucose and lipid metabolism. However, whether brown adipo-
cytes can be recruited in WAT and whether this alters REE or 
macronutrient metabolism remains unclear. Few human models 
mimic the extremity of confining rodents to near-freezing tem-
peratures for several weeks, and in our study of severely burned 
patients, while prolonged stress does indeed brown WAT, several 
other organs are also significantly affected. Thus, to avoid the fate 
of the mitochondrial uncoupler dinitrophenol, future strategies 
aimed at augmenting UCP1 content and function in humans 
must strive to be tissue specific.
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